van Eygen, Veerle

Top Publications

Top Publications Authored or Co-Authored by "van Eygen, Veerle"

• Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

  The Lancet, Volume 396, No. 10267, Year 2020, Citations 129
• Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide

  Antimicrobial Agents and Chemotherapy, Volume 53, No. 5, Year 2009, Citations 65
• Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

  The Lancet HIV, Volume 8, No. 4, Year 2021, Citations 62
• An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing

  Journal of Virological Methods, Volume 204, Year 2014, Citations 59
• Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study

  The Lancet HIV, Volume 8, No. 11, Year 2021, Citations 41